AstraZeneca India Pharma Ltd. (AZPIL), a global, science-led, patient-focused pharmaceutical company, announced that it has received approval from India’s Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of Osimertinib (40mg and 80mg tablets) for an additional indication. This approval marks anadvancement in the treatment of locally...